Clinical trial

Drug-Drug Interaction Study With Rifampin

NCT01002079

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE1

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2011-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

BMS-708163DRUG

RifampinDRUG · verified · RxNorm: rifampin

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

PRA Health Sciencescollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01002079 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.